Scientists track fluid shifts in sepsis patients to personalize resuscitation

NCT ID NCT06499701

Recruiting now Knowledge-focused Sponsor: Institutul de Urgenţă pentru Boli Cardiovasculare Prof.Dr. C.C. Iliescu Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at how a standard dose of IV fluid (Ringer's Lactate) moves between blood and tissues in people with early sepsis. Researchers will measure changes in blood volume and urine output to understand individual differences. The goal is to make fluid treatment more personalized for sepsis patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FLUID AND ELECTROLYTE IMBALANCE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

infectious disease with sepsis Sepsis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

FLUID AND ELECTROLYTE IMBALANCE

Contacts and locations

Locations

"Prof CC Iliescu" Emergency Institue for Cardiovascular Diseases
RECRUITING

Bucharest, 022328, Romania
Fundeni Clinical Institute
RECRUITING

Bucharest, Bucharest, 022328, Romania

More trials for these conditions

Other studies related to the condition(s) this trial covers.